Life Sciences Securities Litigation and Enforcement

Life Sciences

Key Contacts

Recognition

  • Chambers USA: America’s Leading Lawyers for Business (2021) – Again ranked the firm highly, including in Band 1 for Securities Regulation: Nationwide and Band 4 for Securities Litigation: Nationwide. Recent guides highlight our “notable focus on life sciences and technology companies,” our “solid securities litigation practice” and our “market-leading practice in the securities regulatory space.” One source notes that we have an an absolutely terrific team, adding, They know the enforcement world inside and out, and have incredible resources that they can bring to bear when necessary.
  • U.S. News - Best Lawyers® “Best Law Firms” List (2020) – Recognizes our securities litigation and regulation practices at the national level (Tier 1).
  • LMG Life Sciences (2019) again named WilmerHale one of the nation’s leading life sciences firms, recommending our team for Non-IP Litigation & Enforcement, including securities litigation.
  • The Legal 500 United States (2019) – Consistently recognizes the firm in the area of securities litigation—defense. The 2019 guide highlights our “excellent experience and an excellent track record” while clients remarked that the firm has “very deep expertise in securities law matters” and “provides excellent advice and guidance.” Our attorneys are also noted for their “excellent record of trial victories and dismissals for life sciences companies.”

Life Sciences Securities Litigation and Enforcement